Your browser doesn't support javascript.
loading
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario.
Afiliação
  • Giraudo L; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Cattaneo G; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy. giulia.cattaneo@cshs.org.
  • Gammaitoni L; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. giulia.cattaneo@cshs.org.
  • Iaia I; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Donini C; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Massa A; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Centomo ML; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Basiricò M; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Vigna E; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Pisacane A; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Picciotto F; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Berrino E; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Marchiò C; Dermatologic Surgery Section, Department of Surgery, Azienda Ospedaliera Universitaria (AOU) Città Della Salute E Della Scienza, Turin, TO, Italy.
  • Merlini A; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Paruzzo L; Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, TO, Italy.
  • Poletto S; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Caravelli D; Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, TO, Italy.
  • Biolato AM; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Bortolot V; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Landoni E; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Ventin M; Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142 Km 3.95, 10060, Candiolo, TO, Italy.
  • Ferrone CR; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Aglietta M; Cytoskeleton and Cancer Progression, Department of Oncology, Luxembourg Institute of Health, Luxembourg City, Luxembourg.
  • Dotti G; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Sur-Alzette, Luxembourg.
  • Leuci V; Department of Oncology, University of Turin, Regione Gonzole 10, 10043, Orbassano, TO, Italy.
  • Carnevale-Schianca F; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
  • Sangiolo D; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
J Exp Clin Cancer Res ; 42(1): 310, 2023 Nov 22.
Article em En | MEDLINE | ID: mdl-37993874
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Melanoma Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Melanoma Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália